Related Experiment Video

Updated: Jun 16, 2025

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

743

Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis

Marek Z Wojtukiewicz1,2, Marta Mysliwiec3, Anna Tokajuk4

  • 1Department of Oncology, Medical University of Bialystok, 12 Ogrodowa, 15-027, Bialystok, Poland. mzwojtukiewicz@gmail.com.

Cancer Metastasis Reviews
|August 17, 2024
PubMed

Insights

Tissue Factor Pathway Inhibitor-2 (TFPI-2) impacts cancer metastasis through various mechanisms. Reactivating TFPI-2 may offer a promising strategy for future cancer therapy development.

Area of Science:

  • Oncology
  • Hematology
  • Molecular Biology

Background:

  • The coagulation system is implicated in cancer progression and metastasis.
  • The precise mechanisms of coagulation's role in cancer are not fully understood.
  • Tissue Factor Pathway Inhibitor-2 (TFPI-2) is a protease inhibitor with potential anti-cancer functions.

Purpose of the Study:

  • To provide an updated overview of TFPI-2's effects on cancer development and metastasis.
  • To explore the multifaceted roles of TFPI-2 in suppressing tumor growth and spread.
  • To highlight the need for further research into TFPI-2's function and therapeutic potential.

Main Methods:

  • Literature review and synthesis of existing research on TFPI-2.
  • Analysis of TFPI-2's interactions with the thrombin cascade.
  • Examination of TFPI-2's non-coagulation-related anti-cancer mechanisms.

Main Results:

  • TFPI-2 suppresses cancer by stabilizing the extracellular matrix, promoting apoptosis, inhibiting angiogenesis, and modulating intracellular signals.
  • Down-regulation of TFPI-2 expression, often via promoter methylation, is observed in various neoplasms.
  • TFPI-2's interaction with the thrombin cascade contributes to its anti-cancer effects.

Conclusions:

  • TFPI-2 exhibits diverse mechanisms to inhibit cancer development and metastasis.
  • Further investigation is required to fully elucidate TFPI-2's role in cancer progression.
  • Strategies aimed at up-regulating or reactivating TFPI-2 represent a promising avenue for novel cancer therapies.
Keywords:
CancerCoagulationHemostasisMetastasisTissue factor pathway inhibitorTumor

More Related Videos

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

8.4K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

12.9K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K